Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation

Journal of Controlled Release

Volumn 240, Issue , 2016, Pages 109-126

  Soni, Kruti S ^a   Desale, Swapnil S ^a   Bronich, Tatiana K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Clinical; Drug delivery; Imaging; Nanogels; Therapeutic carrier; Translation

Indexed keywords

DISEASE CONTROL; DRUG DELIVERY; FUNCTIONAL POLYMERS; IMAGING TECHNIQUES; MEDICAL APPLICATIONS; MOLECULES; NANOPARTICLES; SITE SELECTION; TRANSLATION (LANGUAGES);

BIOMEDICAL APPLICATIONS; CLINICAL; CLINICAL TRANSLATION; CROSS-LINKED NETWORKS; INORGANIC NANOPARTICLE; NANOGELS; STIMULI-RESPONSIVE; THERAPEUTIC CARRIER;

NANOSTRUCTURED MATERIALS;

CONTRAST MEDIUM; DRUG CARRIER; NANOGEL; NANOPARTICLE; OLIGONUCLEOTIDE; POLYMER; PROTEIN; UNCLASSIFIED DRUG; MACROGOL DERIVATIVE; POLYETHYLENEIMINE;

ARTICLE; CLINICAL PRACTICE; DIAGNOSTIC TEST; DRUG CLEARANCE; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; FLUORESCENCE IMAGING; GEL; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; MULTIMODAL IMAGING; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 1 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STIMULUS RESPONSE; SYNTHESIS; ANIMAL; CHEMISTRY; MEDICAL TECHNOLOGY; PROCEDURES; TRENDS;

ANIMALS; BIOMEDICAL TECHNOLOGY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE;

EID: 84947466113     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.11.009     Document Type: Article

References (251)

1. [1] Rolland, J.P., Maynor, B.W., Euliss, L.E., Exner, A.E., Denison, G.M., DeSimone, J.M., Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. J. Am. Chem. Soc. 127 (2005), 10096–10100.
2. [2] Kersey, F.R., Merkel, T.J., Perry, J.L., Napier, M.E., DeSimone, J.M., Effect of aspect ratio and deformability on nanoparticle extravasation through nanopores. Langmuir 28 (2012), 8773–8781.
3. [3] Kabanov, A.V., Vinogradov, S.V., Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew. Chem. Int. Ed. 48 (2009), 5418–5429.
4. [4] Torchilin, V.P., Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat. Rev. Drug Discov. 13 (2014), 813–827.
5. [5] Zha, L., Banik, B., Alexis, F., Stimulus responsive nanogels for drug delivery. Soft Matter 7 (2011), 5908–5916.
6. [6] Mura, S., Nicolas, J., Couvreur, P., Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12 (2013), 991–1003.
7. [7] Motornov, M., Roiter, Y., Tokarev, I., Minko, S., Stimuli-responsive nanoparticles, nanogels and capsules for integrated multifunctional intelligent systems. Prog. Polym. Sci. 35 (2010), 174–211.
8. [8] Stuart, M.A.C., Huck, W.T., Genzer, J., Müller, M., Ober, C., Stamm, M., et al. Emerging applications of stimuli-responsive polymer materials. Nat. Mater. 9 (2010), 101–113.
9. [9] Oh, J.K., Drumright, R., Siegwart, D.J., Matyjaszewski, K., The development of microgels/nanogels for drug delivery applications. Prog. Polym. Sci. 33 (2008), 448–477.
10. [10] Ayame, H., Morimoto, N., Akiyoshi, K., Self-assembled cationic nanogels for intracellular protein delivery. Bioconjug. Chem. 19 (2008), 882–890.
11. [11] Raemdonck, K., Demeester, J., De Smedt, S., Advanced nanogel engineering for drug delivery. Soft Matter 5 (2009), 707–715.
12. [12] Qiao, Z., Zhang, R., Du, F., Liang, D., Li, Z., Multi-responsive nanogels containing motifs of ortho ester, oligo (ethylene glycol) and disulfide linkage as carriers of hydrophobic anti-cancer drugs. J. Control. Release 152 (2011), 57–66.
13. [13] Oh, J.K., Lee, D.I., Park, J.M., Biopolymer-based microgels/nanogels for drug delivery applications. Prog. Polym. Sci. 34 (2009), 1261–1282.
14. [14] Nochi, T., Yuki, Y., Takahashi, H., Sawada, S., Mejima, M., Kohda, T., et al. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat. Mater. 9 (2010), 572–578.
15. [15] Chacko, R.T., Ventura, J., Zhuang, J., Thayumanavan, S., Polymer nanogels: a versatile nanoscopic drug delivery platform. Adv. Drug Deliv. Rev. 64 (2012), 836–851.
16. [16] McAllister, K., Sazani, P., Adam, M., Cho, M.J., Rubinstein, M., Samulski, R.J., et al. Polymeric nanogels produced via inverse microemulsion polymerization as potential gene and antisense delivery agents. J. Am. Chem. Soc. 124 (2002), 15198–15207.
17. [17] Malmsten, M., Soft drug delivery systems. Soft Matter 2 (2006), 760–769.
18. [18] Napier, M.E., DeSimone, J.M., Nanoparticle drug delivery platform. J. Macromol. Sci. C Polym. Rev. 47 (2007), 321–327.
19. [19] Beija, M., Marty, J., Destarac, M., RAFT/MADIX polymers for the preparation of polymer/inorganic nanohybrids. Prog. Polym. Sci. 36 (2011), 845–886.
20. [20] Siegwart, D.J., Oh, J.K., Matyjaszewski, K., ATRP in the design of functional materials for biomedical applications. Prog. Polym. Sci. 37 (2012), 18–37.
21. [21] Bronich, T.K., Keifer, P.A., Shlyakhtenko, L.S., Kabanov, A.V., Polymer micelle with cross-linked ionic core. J. Am. Chem. Soc. 127 (2005), 8236–8237.
22. [22] O'Reilly, R.K., Hawker, C.J., Wooley, K.L., Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility. Chem. Soc. Rev. 35 (2006), 1068–1083.
23. [23] Oishi, M., Nagasaki, Y., Stimuli-responsive smart nanogels for cancer diagnostics and therapy. Nanomedicine 5 (2010), 451–468.
24. [24] Chiang, W., Ho, V.T., Huang, W., Huang, Y., Chern, C., Chiu, H., Dual stimuli-responsive polymeric hollow nanogels designed as carriers for intracellular triggered drug release. Langmuir 28 (2012), 15056–15064.
25. [25] Sanson, N., Rieger, J., Synthesis of nanogels/microgels by conventional and controlled radical crosslinking copolymerization. Polym. Chem. 1 (2010), 965–977.
26. [26] Elsabahy, M., Heo, G.S., Lim, S., Sun, G., Wooley, K.L., Polymeric nanostructures for imaging and therapy. Chem. Rev., 2015.
27. [27] Desale, S.S., Cohen, S.M., Zhao, Y., Kabanov, A.V., Bronich, T.K., Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer. J. Control. Release 171 (2013), 339–348.
28. [28] Zhang, X., Malhotra, S., Molina, M., Haag, R., Micro-and nanogels with labile crosslinks—from synthesis to biomedical applications. Chem. Soc. Rev. 44 (2015), 1948–1973.
29. [29] Gratton, S.E., Pohlhaus, P.D., Lee, J., Guo, J., Cho, M.J., DeSimone, J.M., Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT™ nanoparticles. J. Control. Release 121 (2007), 10–18.
30. [30] Perry, J.L., Herlihy, K.P., Napier, M.E., DeSimone, J.M., PRINT: a novel platform toward shape and size specific nanoparticle theranostics. Acc. Chem. Res. 44 (2011), 990–998.
31. [31] Glangchai, L.C., Caldorera-Moore, M., Shi, L., Roy, K., Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles. J. Control. Release 125 (2008), 263–272.
32. [32] Sasaki, Y., Akiyoshi, K., Nanogel engineering for new nanobiomaterials: from chaperoning engineering to biomedical applications. Chem. Rec. 10 (2010), 366–376.
33. [33] Water, J.J., Kim, Y., Maltesen, M.J., Franzyk, H., Foged, C., Nielsen, H.M., Hyaluronic acid-based nanogels produced by microfluidics-facilitated self-assembly improves the safety profile of the cationic host defense peptide novicidin. Pharm. Res. 32 (2015), 2727–2735.
34. [34] Lai, H., Wu, P., A infrared spectroscopic study on the mechanism of temperature-induced phase transition of concentrated aqueous solutions of poly(N-isopropylacrylamide) and N-isopropylpropionamide. Polymer 51 (2010), 1404–1412.
35. [35] Jochum, F.D., Theato, P., Temperature-and light-responsive smart polymer materials. Chem. Soc. Rev. 42 (2013), 7468–7483.
36. [36] Mok, H., Jeong, H., Kim, S., Chung, B.H., Indocyanine green encapsulated nanogels for hyaluronidase activatable and selective near infrared imaging of tumors and lymph nodes. Chem. Commun. 48 (2012), 8628–8630.
37. [37] Canal, T., Peppas, N.A., Correlation between mesh size and equilibrium degree of swelling of polymeric networks. J. Biomed. Mater. Res. 23 (1989), 1183–1193.
38. [38] Lustig, S.R., Peppas, N.A., Solute diffusion in swollen membranes. IX. Scaling laws for solute diffusion in gels. J. Appl. Polym. Sci. 36 (1988), 735–747.
39. [39] Eichenbaum, G.M., Kiser, P.F., Simon, S.A., Needham, D., pH and ion-triggered volume response of anionic hydrogel microspheres. Macromolecules 31 (1998), 5084–5093.
40. [40] Oberoi, H.S., Laquer, F.C., Marky, L.A., Kabanov, A.V., Bronich, T.K., Core cross-linked block ionomer micelles as pH-responsive carriers for cis-diamminedichloroplatinum(II). J. Control. Release 153 (2011), 64–72.
41. [41] Tamura, G., Shinohara, Y., Tamura, A., Sanada, Y., Oishi, M., Akiba, I., et al. Dependence of the swelling behavior of a pH-responsive PEG-modified nanogel on the cross-link density. Polym. J. 44 (2012), 240–244.
42. [42] Ricka, J., Tanaka, T., Swelling of ionic gels: quantitative performance of the donnan theory. Macromolecules 17 (1984), 2916–2921.
43. [43] Pikabea, A., Aguirre, G., Miranda, J.I., Ramos, J., Forcada, J., Understanding of nanogels swelling behavior through a deep insight into their morphology. J. Polym. Sci. A Polym. Chem. 53 (2015), 2017–2025.
44. [44] Eichenbaum, G.M., Kiser, P.F., Dobrynin, A.V., Simon, S.A., Needham, D., Investigation of the swelling response and loading of ionic microgels with drugs and proteins: the dependence on cross-link density. Macromolecules 32 (1999), 4867–4878.
45. [45] Tan, B.H., Ravi, P., Tam, K.C., Synthesis and characterization of novel pH-responsive polyampholyte microgels. Macromol. Rapid Commun. 27 (2006), 522–528.
46. [46] Hoare, T., Pelton, R., Charge-switching, amphoteric glucose-responsive microgels with physiological swelling activity. Biomacromolecules 9 (2008), 733–740.
47. [47] Wu, W., Mitra, N., Yan, E.C., Zhou, S., Multifunctional hybrid nanogel for integration of optical glucose sensing and self-regulated insulin release at physiological pH. ACS Nano 4 (2010), 4831–4839.
48. [48] Cheng, R., Meng, F., Deng, C., Klok, H., Zhong, Z., Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 34 (2013), 3647–3657.
49. [49] Morimoto, N., Qiu, X., Winnik, F.M., Akiyoshi, K., Dual stimuli-responsive nanogels by self-assembly of polysaccharides lightly grafted with thiol-terminated poly (N-isopropylacrylamide) chains. Macromolecules 41 (2008), 5985–5987.
50. [50] Pan, Y., Chen, Y., Wang, D., Wei, C., Guo, J., Lu, D., et al. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release. Biomaterials 33 (2012), 6570–6579.
51. [51] Xing, Z., Wang, C., Yan, J., Zhang, L., Li, L., Zha, L., Dual stimuli responsive hollow nanogels with IPN structure for temperature controlling drug loading and pH triggering drug release. Soft Matter 7 (2011), 7992–7997.
52. [52] Xiong, M., Bao, Y., Yang, X., Wang, Y., Sun, B., Wang, J., Lipase-sensitive polymeric triple-layered nanogel for “on-demand” drug delivery. J. Am. Chem. Soc. 134 (2012), 4355–4362.
53. [53] Maciel, D., Figueira, P., Xiao, S., Hu, D., Shi, X., Rodrigues, J., et al. Redox-responsive alginate nanogels with enhanced anticancer cytotoxicity. Biomacromolecules 14 (2013), 3140–3146.
54. [54] Li, M., Tang, Z., Sun, H., Ding, J., Song, W., Chen, X., pH and reduction dual-responsive nanogel cross-linked by quaternization reaction for enhanced cellular internalization and intracellular drug delivery. Polym. Chem. 4 (2013), 1199–1207.
55. [55] Oh, J.K., Siegwart, D.J., Lee, H., Sherwood, G., Peteanu, L., Hollinger, J.O., et al. Biodegradable nanogels prepared by atom transfer radical polymerization as potential drug delivery carriers: synthesis, biodegradation, in vitro release, and bioconjugation. J. Am. Chem. Soc. 129 (2007), 5939–5945.
56. [56] Ryu, J., Chacko, R.T., Jiwpanich, S., Bickerton, S., Babu, R.P., Thayumanavan, S., Self-cross-linked polymer nanogels: a versatile nanoscopic drug delivery platform. J. Am. Chem. Soc. 132 (2010), 17227–17235.
57. [57] Maya, S., Sarmento, B., Nair, A., Rejinold, N.S., Nair, S.V., Jayakumar, R., Smart stimuli sensitive nanogels in cancer drug delivery and imaging: a review. Curr. Pharm. Des. 19 (2013), 7203–7218.
58. [58] Thornton, P.D., Mart, R.J., Ulijn, R.V., Enzyme-responsive polymer hydrogel particles for controlled release. Adv. Mater. 19 (2007), 1252–1256.
59. [59] Kang, H., Trondoli, A.C., Zhu, G., Chen, Y., Chang, Y., Liu, H., et al. Near-infrared light-responsive core–shell nanogels for targeted drug delivery. ACS Nano 5 (2011), 5094–5099.
60. [60] Owens, D.E. III, Peppas, N.A., Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307 (2006), 93–102.
61. [61] Jeon, S.I., Lee, J.H., Andrade, J.D., De Gennes, P.G., Protein-surface interactions in the presence of polyethylene oxide. I. Simplified theory. J. Colloid Interface Sci. 142 (1991), 149–158.
62. [62] Mitragotri, S., Lahann, J., Physical approaches to biomaterial design. Nat. Mater. 8 (2009), 15–23.
63. [63] Jokerst, J.V., Lobovkina, T., Zare, R.N., Gambhir, S.S., Nanoparticle PEGylation for imaging and therapy. Nanomedicine 6 (2011), 715–728.
64. [64] Peracchia, M.T., Fattal, E., Desmaële, D., Besnard, M., Noël, J.P., Gomis, J.M., et al. Stealth(®) PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J. Control. Release 60 (1999), 121–128.
65. [65] Moghimi, S.M., Hunter, A.C., Murray, J.C., Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53 (2001), 283–318.
66. [66] Hendrickson, G.R., Lyon, L.A., Microgel translocation through pores under confinement. Angew. Chem. Int. Ed. 49 (2010), 2193–2197.
67. [67] Banquy, X., Suarez, F., Argaw, A., Rabanel, J., Grutter, P., Bouchard, J., et al. Effect of mechanical properties of hydrogel nanoparticles on macrophage cell uptake. Soft Matter 5 (2009), 3984–3991.
68. [68] Merkel, T.J., Jones, S.W., Herlihy, K.P., Kersey, F.R., Shields, A.R., Napier, M., et al. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 586–591.
69. [69] Anselmo, A.C., Zhang, M., Kumar, S., Vogus, D.R., Menegatti, S., Helgeson, M.E., et al. Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting. ACS Nano 9 (2015), 3169–3177.
70. [70] Zhang, L., Cao, Z., Li, Y., Ella-Menye, J.R., Bai, T., Jiang, S., Softer zwitterionic nanogels for longer circulation and lower splenic accumulation. ACS Nano 6 (2012), 6681–6686.
71. [71] Chen, K., Xu, J., Luft, J.C., Tian, S., Raval, J.S., DeSimone, J.M., Design of asymmetric particles containing a charged interior and a neutral surface charge: comparative study on in vivo circulation of polyelectrolyte microgels. J. Am. Chem. Soc. 136 (2014), 9947–9952.
72. [72] Maeda, H., Bharate, G.Y., Daruwalla, J., Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur. J. Pharm. Biopharm. 71 (2009), 409–419.
73. [73] Maeda, H., The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzym. Regul. 41 (2001), 189–207.
74. [74] Hong, S., Leroueil, P.R., Majoros, I.J., Orr, B.G., Baker, J.R., Holl, M.M.B., The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem. Biol. 14 (2007), 107–115.
75. [75] Danhier, F., Feron, O., Préat, V., To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release 148 (2010), 135–146.
76. [76] Kamaly, N., Xiao, Z., Valencia, P.M., Radovic-Moreno, A.F., Farokhzad, O.C., Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem. Soc. Rev. 41 (2012), 2971–3010.
77. [77] Fang, J., Nakamura, H., Maeda, H., The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliv. Rev. 63 (2011), 136–151.
78. [78] Nuhn, L., Tomcin, S., Miyata, K., Mailänder, V., Landfester, K., Kataoka, K., Zentel, R., Size-dependent knockdown potential of siRNA-loaded cationic nanohydrogel particles. Biomacromolecules 15 (2014), 4111–4121.
79. [79] Ahmed, M., Narain, R., Intracellular delivery of DNA and enzyme in active form using degradable carbohydrate-based nanogels. Mol. Pharm. 9 (2012), 3160–3170.
80. [80] Nuhn, L., Braun, L., Overhoff, I., Kelsch, A., Schaeffel, D., Koynov, K., et al. Degradable cationic nanohydrogel particles for stimuli-responsive release of siRNA. Macromol. Rapid Commun. 35 (2014), 2057–2064.
81. [81] Averick, S.E., Paredes, E., Irastorza, A., Shrivats, A.R., Srinivasan, A., Siegwart, D.J., et al. Preparation of cationic nanogels for nucleic acid delivery. Biomacromolecules 13 (2012), 3445–3449.
82. [82] Torchilin, V.P., Multifunctional nanocarriers. Adv. Drug Deliv. Rev. 64 (2012), 302–315.
83. [83] Desale, S.S., Raja, S.M., Kim, J.O., Mohapatra, B., Soni, K.S., Luan, H., et al. Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models. J. Control. Release 208 (2015), 59–66.
84. [84] Vinogradov, S.V., Batrakova, E.V., Kabanov, A.V., Nanogels for oligonucleotide delivery to the brain. Bioconjug. Chem. 15 (2004), 50–60.
85. [85] Nukolova, N.V., Oberoi, H.S., Cohen, S.M., Kabanov, A.V., Bronich, T.K., Folate-decorated nanogels for targeted therapy of ovarian cancer. Biomaterials 32 (2011), 5417–5426.
86. [86] Nukolova, N.V., Oberoi, H.S., Zhao, Y., Chekhonin, V.P., Kabanov, A.V., Bronich, T.K., LHRH-targeted nanogels as a delivery system for cisplatin to ovarian cancer. Mol. Pharm. 10 (2013), 3913–3921.
87. [87] Vinogradov, S.V., Colloidal microgels in drug delivery applications. Curr. Pharm. Des. 12 (2006), 4703–4712.
88. [88] Bronich, T.K., Vinogradov, S.V., Kabanov, A.V., Interaction of nanosized copolymer networks with oppositely charged amphiphilic molecules. Nano Lett. 1 (2001), 535–540.
89. [89] Kohli, E., Han, H., Zeman, A.D., Vinogradov, S.V., Formulations of biodegradable nanogel carriers with 5′-triphosphates of nucleoside analogs that display a reduced cytotoxicity and enhanced drug activity. J. Control. Release 121 (2007), 19–27.
90. [90] Galmarini, C.M., Warren, G., Kohli, E., Zeman, A., Mitin, A., Vinogradov, S.V., Polymeric nanogels containing the triphosphate form of cytotoxic nucleoside analogues show antitumor activity against breast and colorectal cancer cell lines. Mol. Cancer Ther. 7 (2008), 3373–3380.
91. [91] Gerson, T., Makarov, E., Senanayake, T.H., Gorantla, S., Poluektova, L.Y., Vinogradov, S.V., Nano-NRTIs demonstrate low neurotoxicity and high antiviral activity against HIV infection in the brain. Nanomedicine 10 (2014), 177–185.
92. [92] Kim, J.O., Nukolova, N.V., Oberoi, H.S., Kabanov, A.V., Bronich, T.K., Block ionomer complex micelles with cross-linked cores for drug delivery. Polym. Sci. Ser. A Chem. Phys. 51 (2009), 708–718.
93. [93] Sahay, G., Kim, J.O., Kabanov, A.V., Bronich, T.K., The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents. Biomaterials 31 (2010), 923–933.
94. [94] Kim, J.O., Sahay, G., Kabanov, A.V., Bronich, T.K., Polymeric micelles with ionic cores containing biodegradable cross-links for delivery of chemotherapeutic agents. Biomacromolecules 11 (2010), 919–926.
95. [95] Shi, F., Ding, J., Xiao, C., Zhuang, X., He, C., Chen, L., et al. Intracellular microenvironment responsive PEGylated polypeptide nanogels with ionizable cores for efficient doxorubicin loading and triggered release. J. Mater. Chem. 22 (2012), 14168–14179.
96. [96] Oberoi, H.S., Nukolova, N.V., Laquer, F.C., Poluektova, L.Y., Huang, J., Alnouti, Y., et al. Cisplatin-loaded core cross-linked micelles: comparative pharmacokinetics, antitumor activity, and toxicity in mice. Int. J. Nanomedicine, 7, 2012, 2557.
97. [97] Desale, S.S., Soni, K.S., Romanova, S., Cohen, S.M., Bronich, T.K., Targeted delivery of platinum-taxane combination therapy in ovarian cancer. J. Control. Release, 2015.
98. [98] Peng, J., Qi, T., Liao, J., Chu, B., Yang, Q., Li, W., et al. Controlled release of cisplatin from pH-thermal dual responsive nanogels. Biomaterials 34 (2013), 8726–8740.
99. [99] Kim, J.O., Oberoi, H.S., Desale, S., Kabanov, A.V., Bronich, T.K., Polypeptide nanogels with hydrophobic moieties in the cross-linked ionic cores: synthesis, characterization and implications for anticancer drug delivery. J. Drug Target. 21 (2013), 981–993.
100. [100] Wang, Y., Xu, H., Wang, J., Ge, L., Zhu, J., Development of a thermally responsive nanogel based on chitosan–poly (N-isopropylacrylamide-co-acrylamide) for paclitaxel delivery. J. Pharm. Sci. 103 (2014), 2012–2021.
101. [101] Daoud-Mahammed, S., Couvreur, P., Bouchemal, K., Chéron, M., Lebas, G., Amiel, C., et al. Cyclodextrin and polysaccharide-based nanogels: entrapment of two hydrophobic molecules, benzophenone and tamoxifen. Biomacromolecules 10 (2009), 547–554.
102. [102] Tan, J.P., Tan, M.B., Tam, M.K., Application of nanogel systems in the administration of local anesthetics. Local Reg. Anesth., 3, 2010, 93.
103. [103] Ferrer, M.C.C., Shuvaev, V.V., Zern, B.J., Composto, R.J., Muzykantov, V.R., Eckmann, D.M., Icam-1 targeted nanogels loaded with dexamethasone alleviate pulmonary inflammation. PLoS One, 2014.
104. [104] Ferrer, M.C.C., Ferrier, R.C. Jr., Eckmann, D.M., Composto, R.J., A facile route to synthesize nanogels doped with silver nanoparticles. J. Nanoparticle Res. 15 (2013), 1–7.
105. [105] Ferrer, M.C.C., Dastgheyb, S., Hickok, N.J., Eckmann, D.M., Composto, R.J., Designing nanogel carriers for antibacterial applications. Acta Biomater. 10 (2014), 2105–2111.
106. [106] Nakamura, T., Tamura, A., Murotani, H., Oishi, M., Jinji, Y., Matsuishi, K., et al. Large payloads of gold nanoparticles into the polyamine network core of stimuli-responsive PEGylated nanogels for selective and noninvasive cancer photothermal therapy. Nanoscale 2 (2010), 739–746.
107. [107] Yasui, H., Takeuchi, R., Nagane, M., Meike, S., Nakamura, Y., Yamamori, T., et al. Radiosensitization of tumor cells through endoplasmic reticulum stress induced by PEGylated nanogel containing gold nanoparticles. Cancer Lett. 347 (2014), 151–158.
108. [108] Dias, N., C stein. Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides. Eur. J. Pharm. Biopharm. 54 (2002), 263–269.
109. [109] Leong, P.L., Andrews, G.A., Johnson, D.E., Dyer, K.F., Xi, S., Mai, J.C., et al. Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 4138–4143.
110. [110] Olie, R.A., Simoes-Wust, A.P., Baumann, B., Leech, S.H., Fabbro, D., Stahel, R.A., et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res. 60 (2000), 2805–2809.
111. [111] Seidman, S., Eckstein, F., Grifman, M., Soreq, H., Antisense technologies have a future fighting neurodegenerative diseases. Antisense Nucleic Acid Drug Dev. 9 (1999), 333–340.
112. [112] Ho, S.P., Hartig, P.R., Antisense oligonucleotides for target validation in the CNS. Curr. Opin. Mol. Ther. 1 (1999), 336–343.
113. [113] McCarthy, M.M., Auger, A.P., Mong, J.A., Sickel, M.J., Davis, A.M., Antisense oligodeoxynucleotides as a tool in developmental neuroendocrinology. Methods 22 (2000), 239–248.
114. [114] Agrawal, S., Ikeuchi, T., Sun, D., Sarin, P.S., Konopka, A., Maizel, J., et al. Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues. Proc. Natl. Acad. Sci. U. S. A. 86 (1989), 7790–7794.
115. [115] Wu, G.Y., Wu, C.H., Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides. J. Biol. Chem. 267 (1992), 12436–12439.
116. [116] Janssen, H.L., Reesink, H.W., Lawitz, E.J., Zeuzem, S., Rodriguez-Torres, M., Patel, K., et al. Treatment of HCV infection by targeting microRNA. N. Engl. J. Med. 368 (2013), 1685–1694.
117. [117] Kim, D.H., Rossi, J.J., Strategies for silencing human disease using RNA interference. Nat. Rev. Genet. 8 (2007), 173–184.
118. [118] Kanasty, R., Dorkin, J.R., Vegas, A., Anderson, D., Delivery materials for siRNA therapeutics. Nat. Mater. 12 (2013), 967–977.
119. [119] Vinogradov, S., Batrakova, E., Kabanov, A., Poly (ethylene glycol)–polyethyleneimine NanoGel™ particles: novel drug delivery systems for antisense oligonucleotides. Colloids Surf. B: Biointerfaces 16 (1999), 291–304.
120. [120] Tamura, A., Oishi, M., Nagasaki, Y., Enhanced cytoplasmic delivery of siRNA using a stabilized polyion complex based on PEGylated nanogels with a cross-linked polyamine structure. Biomacromolecules 10 (2009), 1818–1827.
121. [121] Mimi, H., Ho, K.M., Siu, Y.S., Wu, A., Li, P., Polyethyleneimine-based core–shell nanogels: a promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells. J. Control. Release 158 (2012), 123–130.
122. [122] Raemdonck, K., Naeye, B., Buyens, K., Vandenbroucke, R.E., Høgset, A., Demeester, J., et al. Biodegradable dextran nanogels for RNA interference: focusing on endosomal escape and intracellular siRNA delivery. Adv. Funct. Mater. 19 (2009), 1406–1415.
123. [123] Ahmed, M., Wattanaarsakit, P., Narain, R., Cationic glyco-nanogels for epidermal growth factor receptor (EGFR) specific siRNA delivery in ovarian cancer cells. Polym. Chem. 4 (2013), 3829–3836.
124. [124] De Backer, L., Braeckmans, K., Stuart, M.C., Demeester, J., De Smedt, S.C., Raemdonck, K., Bio-inspired pulmonary surfactant-modified nanogels: a promising siRNA delivery system. J. Control. Release 206 (2015), 177–186.
125. [125] Pereira, P., Morgado, D., Crepet, A., David, L., Gama, F.M., Glycol chitosan-based nanogel as a potential targetable carrier for siRNA. Macromol. Biosci. 13 (2013), 1369–1378.
126. [126] Smith, M.H., Lyon, L.A., Multifunctional nanogels for siRNA delivery. Acc. Chem. Res. 45 (2011), 985–993.
127. [127] Naeye, B., Raemdonck, K., Remaut, K., Sproat, B., Demeester, J., De Smedt, S., PEGylation of biodegradable dextran nanogels for siRNA delivery. Eur. J. Pharm. Sci. 40 (2010), 342–351.
128. [128] Fujii, H., Shin-Ya, M., Takeda, S., Hashimoto, Y., Mukai, S., Sawada, S., et al. Cycloamylose-nanogel drug delivery system-mediated intratumor silencing of the vascular endothelial growth factor regulates neovascularization in tumor microenvironment. Cancer Sci. 105 (2014), 1616–1625.
129. [129] Siegwart, D.J., Whitehead, K.A., Nuhn, L., Sahay, G., Cheng, H., Jiang, S., et al. Combinatorial synthesis of chemically diverse core–shell nanoparticles for intracellular delivery. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 12996–13001.
130. [130] Ramos, J., Forcada, J., Hidalgo-Alvarez, R., Cationic polymer nanoparticles and nanogels: from synthesis to biotechnological applications. Chem. Rev. 114 (2013), 367–428.
131. [131] Nishikawa, T., Akiyoshi, K., J sunamoto. Supramolecular assembly between nanoparticles of hydrophobized polysaccharide and soluble protein complexation between the self-aggregate of cholesterol-bearing pullulan and alpha-chymotrypsin. Macromolecules 27 (1994), 7654–7659.
132. [132] Akiyoshi, K., Kobayashi, S., Shichibe, S., Mix, D., Baudys, M., Kim, S.W., et al. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin. J. Control. Release 54 (1998), 313–320.
133. [133] Hasegawa, U., Sawada, S., Shimizu, T., Kishida, T., Otsuji, E., Mazda, O., et al. Raspberry-like assembly of cross-linked nanogels for protein delivery. J. Control. Release 140 (2009), 312–317.
134. [134] Nagahama, K., Ouchi, T., Ohya, Y., Biodegradable nanogels prepared by self-assembly of poly (L-lactide)-grafted dextran: entrapment and release of proteins. Macromol. Biosci. 8 (2008), 1044–1052.
135. [135] Van Thienen, T., Raemdonck, K., Demeester, J., De Smedt, S., Protein release from biodegradable dextran nanogels. Langmuir 23 (2007), 9794–9801.
136. [136] Ganguly, K., Chaturvedi, K., More, U.A., Nadagouda, M.N., Aminabhavi, T.M., Polysaccharide-based micro/nanohydrogels for delivering macromolecular therapeutics. J. Control. Release 193 (2014), 162–173.
137. [137] Siegwart, D.J., Srinivasan, A., Bencherif, S.A., Karunanidhi, A., Oh, J.K., Vaidya, S., et al. Cellular uptake of functional nanogels prepared by inverse miniemulsion ATRP with encapsulated proteins, carbohydrates, and gold nanoparticles. Biomacromolecules 10 (2009), 2300–2309.
138. [138] Wutzel, H., Richter, F.H., Li, Y., Sheiko, S.S., Klok, H., Poly [N-(2-hydroxypropyl) methacrylamide] nanogels by RAFT polymerization in inverse emulsion. Polym. Chem. 5 (2014), 1711–1719.
139. [139] Chen, W., Zheng, M., Meng, F., Cheng, R., Deng, C., Feijen, J., et al. In situ forming reduction-sensitive degradable nanogels for facile loading and triggered intracellular release of proteins. Biomacromolecules 14 (2013), 1214–1222.
140. [140] Amidi, M., Romeijn, S.G., Borchard, G., Junginger, H.E., Hennink, W.E., Jiskoot, W., Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J. Control. Release 111 (2006), 107–116.
141. [141] Ferreira, S.A., Gama, F.M., Vilanova, M., Polymeric nanogels as vaccine delivery systems. Nanomedicine 9 (2013), 159–173.
142. [142] Gutierro, I., Hernández, R.M., Igartua, M., Gascón, A.R., Pedraz, J.L., Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Vaccine 21 (2002), 67–77.
143. [143] Oyewumi, M.O., Kumar, A., Cui, Z., Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Rev. Vaccines 9 (2010), 1095–1107.
144. [144] Kitano, S., Kageyama, S., Nagata, Y., Miyahara, Y., Hiasa, A., Naota, H., et al. HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan. Clin. Cancer Res. 12 (2006), 7397–7405.
145. [145] Uenaka, A., Wada, H., Isobe, M., Saika, T., Tsuji, K., Sato, E., et al. T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein. Cancer Immun., 7, 2007, 9.
146. [146] Kageyama, S., Wada, H., Muro, K., Niwa, Y., Ueda, S., Miyata, H., et al. Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients. J. Transl. Med., 11, 2013, 246.
147. [147] Saito, T., Wada, H., Yamasaki, M., Miyata, H., Nishikawa, H., Sato, E., et al. High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine. Vaccine 32 (2014), 5901–5907.
148. [148] Tahara, Y., Akiyoshi, K., Current advances in self-assembled nanogels for immunotherapy. Adv. Drug Deliv. Rev., 2015.
149. [149] Woodcock, J., Griffin, J.P., Behrman, R.E., Development of novel combination therapies. N. Engl. J. Med. 364 (2011), 985–987.
150. [150] Park, J., Wrzesinski, S.H., Stern, E., Look, M., Criscione, J., Ragheb, R., et al. Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy. Nat. Mater. 11 (2012), 895–905.
151. [151] Kamolratanakul, P., Hayata, T., Ezura, Y., Kawamata, A., Hayashi, C., Yamamoto, Y., et al. Nanogel-based scaffold delivery of prostaglandin E2 receptor-specific agonist in combination with a low dose of growth factor heals critical-size bone defects in mice. Arthritis Rheum. 63 (2011), 1021–1033.
152. [152] Toita, S., Sawada, S., Akiyoshi, K., Polysaccharide nanogel gene delivery system with endosome-escaping function: co-delivery of plasmid DNA and phospholipase A2. J. Control. Release 155 (2011), 54–59.
153. [153] Katagiri, K., Ohta, K., Koumoto, K., Kurosu, K., Sasaki, Y., Akiyoshi, K., Templated nucleation of hybrid iron oxide nanoparticles on polysaccharide nanogels. Colloid Polym. Sci. 291 (2013), 1375–1380.
154. [154] Choo, E.S.G., Tang, X., Sheng, Y., Shuter, B., Xue, J., Controlled loading of superparamagnetic nanoparticles in fluorescent nanogels as effective T 2-weighted MRI contrast agents. J. Mater. Chem. 21 (2011), 2310–2319.
155. [155] Terreno, E., Castelli, D.D., Viale, A., Aime, S., Challenges for molecular magnetic resonance imaging. Chem. Rev. 110 (2010), 3019–3042.
156. [156] Soleimani, A., Martínez, F., Economopoulos, V., Foster, P.J., Scholl, T.J., Gillies, E.R., Polymer cross-linking: a nanogel approach to enhancing the relaxivity of MRI contrast agents. J. Mater. Chem. B 1 (2013), 1027–1034.
157. [157] Paquet, C., de Haan, H.W., Leek, D.M., Lin, H., Xiang, B., Tian, G., et al. Clusters of superparamagnetic iron oxide nanoparticles encapsulated in a hydrogel: a particle architecture generating a synergistic enhancement of the T2 relaxation. ACS Nano 5 (2011), 3104–3112.
158. [158] Bloembergen, N., Purcell, E.M., Pound, R.V., Relaxation effects in nuclear magnetic resonance absorption. Phys. Rev., 73, 1948, 679.
159. [159] Shapiro, Y.E., Structure and dynamics of hydrogels and organogels: an NMR spectroscopy approach. Prog. Polym. Sci. 36 (2011), 1184–1253.
160. [160] Okada, S., Mizukami, S., Matsumura, Y., Yoshioka, Y., Kikuchi, K., A nanospherical polymer as an MRI sensor without paramagnetic or superparamagnetic species. Dalton Trans. 42 (2013), 15864–15867.
161. [161] Nicolle, G.M., Tóth, É., Schmitt-Willich, H., Radüchel, B., Merbach, A.E., The impact of rigidity and water exchange on the relaxivity of a dendritic MRI contrast agent. Chem. Eur. J. 8 (2002), 1040–1048.
162. [162] Rudovský, J., Hermann, P., Botta, M., Aime, S., Lukeš, I., Dendrimeric Gd (III) complex of a monophosphinated DOTA analogue: optimizing relaxivity by reducing internal motion. Chem. Commun., 2005, 2390–2392.
163. [163] Lux, J., Chan, M., Vander Elst, L., Schopf, E., Mahmoud, E., Laurent, S., et al. Metal chelating crosslinkers form nanogels with high chelation stability. J. Mater. Chem. B 1 (2013), 6359–6364.
164. [164] Lewinski, N., Colvin, V., Drezek, R., Cytotoxicity of nanoparticles. Small 4 (2008), 26–49.
165. [165] Wu, W., Zhou, S., Hybrid micro −/nanogels for optical sensing and intracellular imaging. Nano Rev., 1, 2010.
166. [166] Wu, W., Aiello, M., Zhou, T., Berliner, A., Banerjee, P., Zhou, S., In-situ immobilization of quantum dots in polysaccharide-based nanogels for integration of optical pH-sensing, tumor cell imaging, and drug delivery. Biomaterials 31 (2010), 3023–3031.
167. [167] Chen, Y., Zheng, X., Wang, X., Wang, C., Ding, Y., Jiang, X., Near-infrared emitting gold cluster–poly (acrylic acid) hybrid nanogels. ACS Macro Lett. 3 (2013), 74–76.
168. [168] Kim, J., Piao, Y., Hyeon, T., Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem. Soc. Rev. 38 (2009), 372–390.
169. [169] Wiley, B., Sun, Y., Xia, Y., Synthesis of silver nanostructures with controlled shapes and properties. Acc. Chem. Res. 40 (2007), 1067–1076.
170. [170] Jain, P.K., Huang, X., El-Sayed, I.H., El-Sayed, M.A., Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc. Chem. Res. 41 (2008), 1578–1586.
171. [171] Lim, S.I., Zhong, C.J., Molecularly mediated processing and assembly of nanoparticles: exploring the interparticle interactions and structures. Acc. Chem. Res. 42 (2009), 798–808.
172. [172] Qian, X., Li, J., Nie, S., Stimuli-responsive SERS nanoparticles: conformational control of plasmonic coupling and surface Raman enhancement. J. Am. Chem. Soc. 131 (2009), 7540–7541.
173. [173] Xiao, J., Tian, X., Yang, C., Liu, P., Luo, N., Liang, Y., et al. Ultrahigh relaxivity and safe probes of manganese oxide nanoparticles for in vivo imaging. Sci. Rep., 3, 2013, 3424.
174. [174] Aime, S., Caravan, P., Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. J. Magn. Reson. Imaging 30 (2009), 1259–1267.
175. [175] Lim, C., Singh, A., Heo, J., Kim, D., Lee, K.E., Jeon, H., et al. Gadolinium-coordinated elastic nanogels for in vivo tumor targeting and imaging. Biomaterials 34 (2013), 6846–6852.
176. [176] Stark, D.D., Weissleder, R., Elizondo, G., Hahn, P.F., Saini, S., Todd, L.E., et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 168 (1988), 297–301.
177. [177] Weissleder, R., Elizondo, G., Wittenberg, J., Lee, A.S., Josephson, L., Brady, T.J., Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175 (1990), 494–498.
178. [178] Jun, Y., Huh, Y., Choi, J., Lee, J., Song, H., Kim, S., et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J. Am. Chem. Soc. 127 (2005), 5732–5733.
179. [179] Katagiri, K., Ohta, K., Sako, K., Inumaru, K., Hayashi, K., Sasaki, Y., et al. Development and potential theranostic applications of a self-assembled hybrid of magnetic nanoparticle clusters with polysaccharide nanogels. ChemPlusChem 79 (2014), 1631–1637.
180. [180] Wang, X., Niu, D., Wu, Q., Bao, S., Su, T., Liu, X., et al. Iron oxide/manganese oxide co-loaded hybrid nanogels as pH-responsive magnetic resonance contrast agents. Biomaterials 53 (2015), 349–357.
181. [181] Oishi, M., Sumitani, S., Bronich, T.K., Kabanov, A.V., Boska, M.D., Nagasaki, Y., Novel 19F MRS/I nanoprobe based on pH-responsive PEGylated nanogel: pH-dependent 19F magnetic resonance studies. Chem. Lett. 38 (2009), 128–129.
182. [182] Lux, J., White, A.G., Chan, M., Anderson, C.J., Almutairi, A., Nanogels from metal-chelating crosslinkers as versatile platforms applied to copper-64 PET imaging of tumors and metastases. Theranostics, 5, 2015, 277.
183. [183] Singh, S., Bingöl, B., Morgenroth, A., Mottaghy, F.M., Möller, M., Schmaljohann, J., Radiolabeled nanogels for nuclear molecular imaging. Macromol. Rapid Commun. 34 (2013), 562–567.
184. [184] Michalet, X., Pinaud, F.F., Bentolila, L.A., Tsay, J.M., Doose, S., Li, J.J., et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307 (2005), 538–544.
185. [185] Weissleder, R., A clearer vision for in vivo imaging. Nat. Biotechnol. 19 (2001), 316–317.
186. [186] Yu, J., Javier, D., Yaseen, M.A., Nitin, N., Richards-Kortum, R., Anvari, B., et al. Self-assembly synthesis, tumor cell targeting, and photothermal capabilities of antibody-coated indocyanine green nanocapsules. J. Am. Chem. Soc. 132 (2010), 1929–1938.
187. [187] Park, H.S., Lee, J.E., Cho, M.Y., Hong, J.H., Cho, S.H., Lim, Y.T., Hyaluronic acid/poly (β-amino ester) polymer nanogels for cancer-cell-specific NIR fluorescence switch. Macromol. Rapid Commun. 33 (2012), 1549–1555.
188. [188] Kim, J., Chong, Y., Mok, H., Shell-crosslinked hyaluronic acid nanogels for live monitoring of hyaluronidase activity in vivo. Macromol. Biosci. 14 (2014), 881–888.
189. [189] Dai, T., Zhou, S., Yin, C., Li, S., Cao, W., Liu, W., et al. Dextran-based fluorescent nanoprobes for sentinel lymph node mapping. Biomaterials 35 (2014), 8227–8235.
190. [190] Noh, Y., Kong, S., Choi, D., Park, H.S., Yang, H., Lee, H., et al. Near-infrared emitting polymer nanogels for efficient sentinel lymph node mapping. ACS Nano 6 (2012), 7820–7831.
191. [191] Kong, S., Noh, Y., Suh, Y., Park, H.S., Lee, H., Kang, K.W., et al. Evaluation of the novel near-infrared fluorescence tracers pullulan polymer nanogel and indocyanine green/γ-glutamic acid complex for sentinel lymph node navigation surgery in large animal models. Gastric Cancer 18 (2015), 55–64.
192. [192] Molina, M., Asadian-Birjand, M., Balach, J., Bergueiro, J., Miceli, E., Calderón, M., Stimuli-responsive nanogel composites and their application in nanomedicine. Chem. Soc. Rev. 44 (2015), 6161–6186.
193. [193] Cherry, S.R., Multimodality in vivo imaging systems: twice the power or double the trouble?. Annu. Rev. Biomed. Eng. 8 (2006), 35–62.
194. [194] Huang, R., Ke, W., Liu, Y., Jiang, C., Pei, Y., The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain. Biomaterials 29 (2008), 238–246.
195. [195] Xie, H., Zhu, Y., Jiang, W., Zhou, Q., Yang, H., Gu, N., et al. Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo. Biomaterials 32 (2011), 495–502.
196. [196] Jiang, L., Zhou, Q., Mu, K., Xie, H., Zhu, Y., Zhu, W., et al. pH/temperature sensitive magnetic nanogels conjugated with Cy5. 5-labled lactoferrin for MR and fluorescence imaging of glioma in rats. Biomaterials 34 (2013), 7418–7428.
197. [197] Kim, H.M., Noh, Y., Park, H.S., Cho, M.Y., Hong, K.S., Lee, H., et al. Self-fluorescence of chemically crosslinked MRI nanoprobes to enable multimodal imaging of therapeutic cells. Small 8 (2012), 666–670.
198. [198] Ruhland, T.M., Reichstein, P.M., Majewski, A.P., Walther, A., Müller, A.H.E., Superparamagnetic and fluorescent thermo-responsive core–shell–corona hybrid nanogels with a protective silica shell. J. Colloid Interface Sci. 374 (2012), 45–53.
199. [199] Wang, X., Niu, D., Li, P., Wu, Q., Bo, X., Liu, B., et al. A dual-enzyme loaded multifunctional hybrid nanogel system for pathological responsive ultrasound imaging and T2-weighted magnetic resonance imaging. ACS Nano 9 (2015), 5646–5656.
200. [200] Thornton, P.D., Mart, R.J., Webb, S.J., Ulijn, R.V., Enzyme-responsive hydrogel particles for the controlled release of proteins: designing peptide actuators to match payload. Soft Matter 4 (2008), 821–827.
201. [201] Wang, Q., Yang, Z., Zhang, X., Xiao, X., Chang, C., Xu, B., A supramolecular-hydrogel-encapsulated hemin as an artificial enzyme to mimic peroxidase. Angew. Chem. Int. Ed. 46 (2007), 4285–4289.
202. [202] Vinogradov, S.V., Nanogels in the race for drug delivery. Nanomedicine, 5, 2010, 165.
203. [203] Li, Y., Xiao, K., Zhu, W., Deng, W., Lam, K.S., Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers. Adv. Drug Deliv. Rev. 66 (2014), 58–73.
204. [204] Moghimi, S.M., Porter, C.J.H., Muir, I.S., Illum, L., Davis, S.S., Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. Biochem. Biophys. Res. Commun. 177 (1991), 861–866.
205. [205] Gref, R., Domb, A., Quellec, P., Blunk, T., Müller, R.H., Verbavatz, J.M., et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv. Drug Deliv. Rev. 64 (2012), 316–326 (Supplement).
206. [206] Elsabahy, M., Wooley, K.L., Design of polymeric nanoparticles for biomedical delivery applications. Chem. Soc. Rev. 41 (2012), 2545–2561.
207. [207] Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2 (2007), 249–255.
208. [208] Tamura, M., Ichinohe, S., Tamura, A., Ikeda, Y., Nagasaki, Y., In vitro and in vivo characteristics of core–shell type nanogel particles: optimization of core cross-linking density and surface poly(ethylene glycol) density in PEGylated nanogels. Acta Biomater. 7 (2011), 3354–3361.
209. [209] Shiraishi, K., Hamano, M., Ma, H., Kawano, K., Maitani, Y., Aoshi, T., et al. Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon. J. Control. Release 165 (2013), 183–190.
210. [210] Ishihara, T., Takeda, M., Sakamoto, H., Kimoto, A., Kobayashi, C., Takasaki, N., et al. Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles. Pharm. Res. 26 (2009), 2270–2279.
211. [211] Ishida, T., Harada, M., Wang, X.Y., Ichihara, M., Irimura, K., Kiwada, H., Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes. J. Control. Release 105 (2005), 305–317.
212. [212] Saadati, R., Dadashzadeh, S., Abbasian, Z., Soleimanjahi, H., Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug. Pharm. Res. 30 (2013), 985–995.
213. [213] Lau, K.H., Ren, C., Sileika, T.S., Park, S.H., Szleifer, I., Messersmith, P.B., Surface-grafted polysarcosine as a peptoid antifouling polymer brush. Langmuir 28 (2012), 16099–16107.
214. [214] Hara, E., Ueda, M., Kim, C.J., Makino, A., Hara, I., Ozeki, E., et al. Suppressive immune response of poly-(sarcosine) chains in peptide-nanosheets in contrast to polymeric micelles. J. Pept. Sci. 20 (2014), 570–577.
215. [215] Huesmann, D., Sevenich, A., Weber, B., Barz, M., A head-to-head comparison of poly (sarcosine) and poly (ethylene glycol) in peptidic, amphiphilic block copolymers. Polymer 67 (2015), 240–248.
216. [216] Campbell, R.B., Fukumura, D., Brown, E.B., Mazzola, L.M., Izumi, Y., Jain, R.K., et al. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Cancer Res. 62 (2002), 6831–6836.
217. [217] Nakamura, M., Davila-Zavala, P., Tokuda, H., Takakura, Y., Hashida, M., Uptake and gene expression of naked plasmid DNA in cultured brain microvessel endothelial cells. Biochem. Biophys. Res. Commun. 245 (1998), 235–239.
218. [218] Lv, H., Zhang, S., Wang, B., Cui, S., Yan, J., Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release 114 (2006), 100–109.
219. [219] Kim, Y.H., Park, J.H., Lee, M., Kim, Y., Park, T.G., Kim, S.W., Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. J. Control. Release 103 (2005), 209–219.
220. [220] Fischer, A., Hacein-Bey-Abina, S., Lagresle, C., Garrigue, A., Cavazana-Calvo, M., Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome. Bull. Acad. Natl Med., 189, 2005, 779.
221. [221] Itaka, K., Kataoka, K., Recent development of nonviral gene delivery systems with virus-like structures and mechanisms. Eur. J. Pharm. Biopharm. 71 (2009), 475–483.
222. [222] Reischl, D., Zimmer, A., Drug delivery of siRNA therapeutics: potentials and limits of nanosystems. Nanomedicine 5 (2009), 8–20.
223. [223] Wang, J., Lu, Z., Wientjes, M.G., Au, J.L., Delivery of siRNA therapeutics: barriers and carriers. AAPS J. 12 (2010), 492–503.
224. [224] Zuckerman, J.E., Choi, C.H., Han, H., Davis, M.E., Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 3137–3142.
225. [225] Naeye, B., Deschout, H., Caveliers, V., Descamps, B., Braeckmans, K., Vanhove, C., et al. In vivo disassembly of IV administered siRNA matrix nanoparticles at the renal filtration barrier. Biomaterials 34 (2013), 2350–2358.
226. [226] Frokjaer, S., Otzen, D.E., Protein drug stability: a formulation challenge. Nat. Rev. Drug Discov. 4 (2005), 298–306.
227. [227] Krishnamurthy, R., Manning, M.C., The stability factor: importance in formulation development. Curr. Pharm. Biotechnol. 3 (2002), 361–371.
228. [228] Kamerzell, T.J., Esfandiary, R., Joshi, S.B., Middaugh, C.R., Volkin, D.B., Protein–excipient interactions: mechanisms and biophysical characterization applied to protein formulation development. Adv. Drug Deliv. Rev. 63 (2011), 1118–1159.
229. [229] Heldin, C., Rubin, K., Pietras, K., Östman, A., High interstitial fluid pressure—an obstacle in cancer therapy. Nat. Rev. Cancer 4 (2004), 806–813.
230. [230] Singh, A., Talekar, M., Tran, T., Samanta, A., Sundaram, R., Amiji, M., Combinatorial approach in the design of multifunctional polymeric nano-delivery systems for cancer therapy. J. Mater. Chem. B, 2014.
231. [231] Maki, S., Konno, T., Maeda, H., Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium. Cancer 56 (1985), 751–757.
232. [232] Seynhaeve, A.L., Hoving, S., Schipper, D., Vermeulen, C.E., de Wiel-Ambagtsheer, G., van Tiel, S.T., et al. Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response. Cancer Res. 67 (2007), 9455–9462.
233. [233] Kano, M.R., Bae, Y., Iwata, C., Morishita, Y., Yashiro, M., Oka, M., et al. Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 3460–3465.
234. [234] Wang, Y., Zhao, R., Russell, R.G., Goldman, I.D., Localization of the murine reduced folate carrier as assessed by immunohistochemical analysis. Biochim. Biophys. Acta Biomembr. 1513 (2001), 49–54.
235. [235] Desmoulin, S.K., Hou, Z., Gangjee, A., Matherly, L.H., The human proton-coupled folate transporter: biology and therapeutic applications to cancer. Cancer Biol. Ther. 13 (2012), 1355–1373.
236. [236] Ross, J.F., Chaudhuri, P.K., Ratnam, M., Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73 (1994), 2432–2443.
237. [237] Parker, N., Turk, M.J., Westrick, E., Lewis, J.D., Low, P.S., Leamon, C.P., Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal. Biochem. 338 (2005), 284–293.
238. [238] Weitman, S.D., Lark, R.H., Coney, L.R., Fort, D.W., Frasca, V., Zurawski, V.R. Jr., et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52 (1992), 3396–3401.
239. [239] Allen, T.M., Ligand-targeted therapeutics in anticancer therapy. Nat. Rev. Cancer 2 (2002), 750–763.
240. [240] Michaelsen, T.E., Brekke, O.H., Aase, A., Sandin, R.H., Bremnes, B., Sandlie, I., One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hinge. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 9243–9247.
241. [241] Seegan, G.W., Smith, C.A., Schumaker, V.N., Changes in quaternary structure of IgG upon reduction of the interheavy-chain disulfide bond. Proc. Natl. Acad. Sci. U. S. A. 76 (1979), 907–911.
242. [242] Junutula, J.R., Raab, H., Clark, S., Bhakta, S., Leipold, D.D., Weir, S., et al. Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index. Nat. Biotechnol. 26 (2008), 925–932.
243. [243] Wang, L., Amphlett, G., Blättler, W.A., Lambert, J.M., Zhang, W., Structural characterization of the maytansinoid–monoclonal antibody immunoconjugate, huN901–DM1, by mass spectrometry. Protein Sci. 14 (2005), 2436–2446.
244. [244] Stimmel, J.B., Merrill, B.M., Kuyper, L.F., Moxham, C.P., Hutchins, J.T., Fling, M.E., et al. Site-specific conjugation on serine right-arrow cysteine variant monoclonal antibodies. J. Biol. Chem. 275 (2000), 30445–30450.
245. [245] McDonagh, C.F., Turcott, E., Westendorf, L., Webster, J.B., Alley, S.C., Kim, K., et al. Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment. Protein Eng. Des. Sel. 19 (2006), 299–307.
246. [246] Shi, M., Lu, J., Shoichet, M.S., Organic nanoscale drug carriers coupled with ligands for targeted drug delivery in cancer. J. Mater. Chem. 19 (2009), 5485–5498.
247. [247] Phillips, M.A., Gran, M.L., Peppas, N.A., Targeted nanodelivery of drugs and diagnostics. Nano Today 5 (2010), 143–159.
248. [248] Vercauteren, R., Bruneel, D., Schacht, E., Duncan, R., Effect of the chemical modification of dextran on the degradation by dextranase. J. Bioact. Compat. Polym. 5 (1990), 4–15.
249. [249] Huang, X., Brazel, C.S., On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J. Control. Release 73 (2001), 121–136.
250. [250] Arifin, D.Y., Lee, L.Y., Wang, C., Mathematical modeling and simulation of drug release from microspheres: implications to drug delivery systems. Adv. Drug Deliv. Rev. 58 (2006), 1274–1325.
251. [251] Tan, J.P.K., Wang, Q., Tam, K.C., Control of burst release from nanogels via layer by layer assembly. J. Control. Release 128 (2008), 248–254.